GoodRx Holdings, Inc. (GDRX) Stock Overview
Explore GoodRx Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.
GoodRx Holdings, Inc. (GDRX)
Key Financials
Key Financials
Market Cap
1B
P/E Ratio
50.09
EPS (TTM)
$0.33
ROE
0.03%
GDRX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of GoodRx Holdings, Inc. (NASDAQ: GDRX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, GoodRx Holdings, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of GDRX on the NASDAQ shows an RSI of 51.77, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1.46 for the NASDAQ listing.
Key metrics behind GoodRx Holdings, Inc.'s NASDAQ-traded stock include a P/E ratio of 50.09 and a market capitalization of 1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of GDRX on the NASDAQ.